Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3200
Abstract: Abstract Background Conflicting results has been reported regard osteoporosis and fractures in patients with Differentiated Thyroid Cancer (DTC). Our objective was to evaluate the long‐term effects of TSH suppression therapy with Levothyroxine (LT4) on trabecular…
read more here.
Keywords:
tsh;
bone;
cancer;
therapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000031991
Abstract: Background: The effect of thyroid stimulating endocrine (TSH) suppression medical aid on bone mineral density (BMD) of patients with differentiated thyroid carcinoma (DTC) or differentiated thyroid malignant neoplastic disease is still controversial. Our aim was…
read more here.
Keywords:
tsh suppression;
suppression therapy;
bmd;
dtc patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical Endocrinology"
DOI: 10.1111/cen.14698
Abstract: Thyrotropin (TSH) suppression therapy is a standard treatment after surgery for differentiated thyroid carcinoma (DTC). It may be associated with osteoporosis in postmenopausal women. However, there are no guidelines for bone mineral density (BMD) testing…
read more here.
Keywords:
tsh suppression;
suppression therapy;
thyroid carcinoma;
differentiated thyroid ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Endocrine journal"
DOI: 10.1507/endocrj.ej20-0134
Abstract: Thyroid stimulating hormone (TSH) suppression therapy after thyroid carcinoma surgery could lead to cognitive impairment. But, the possible mechanism of TSH suppression therapy impairs cognitive function is yet unknown. In this study, forty Wistar rats…
read more here.
Keywords:
suppression therapy;
group;
mtor;
therapy ... See more keywords